Pharmaceutical

How big data M&A performed in the pharmaceutical industry in Q2 2023

In the global pharmaceutical industry, there were 3 M&A deals announced in Q2 2023, worth a total value of $800m, according to GlobalData's Deals Database.

Jul 31, 2023 - 20:00
In the global pharmaceutical industry, there were 3 M&A deals announced in Q2 2023, worth a total value of $800m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

How regenerative medicine M&A performed in the pharmaceutical industry in Q2 2023

Next Article

How immuno-oncology private equity performed in the pharmaceutical industry in Q...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

China’s NMPA approves Antengene’s XPOVIO for DLBCL

China’s NMPA approves Antengene’s XPOVIO for DLBCL

Jul 10, 2024

Risk adjusted net present value: What is the current va...

Nov 18, 2023

STAT+: Biotech launches with $300 million, joint venture to expedite RNA drug development

STAT+: Biotech launches with $300 million, joint ventur...

May 23, 2023